67 /100
HIGH RISK
Score updated May 30, 2026

XRTX — XORTX Therapeutics Inc. Dilution Risk Tracker

Track XRTX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track XRTX — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
95
📊 Float Risk
30
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
34%
💰 Capital Raise 55%
• Critical: only 1.9 months cash remaining
🔄 Reverse Split 15%
• Only 2 months cash — financial pressure
📉 Score Deterioration 10%
• Score in HIGH risk zone (67/100)
🔔 Track XRTX — Get forecast alerts →

💹 Market Data

Market Cap$3.98M
Shares Outstanding1.73M
Float1.37M
Cash$250.3K
Debt$15.1K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 126.9% shares (2025Q4 vs prior)
6 institutional holders · 230.7K shares
#1 DRW Securities, LLC 193.6K shares
#2 Baader Bank Aktiengesellschaft 18.7K shares
#3 TWO SIGMA SECURITIES, LLC 12.6K shares
+ 3 more holders Sign up free to view →

📉 Short Interest

Short Interest53.6K
Days to Cover1.3
% of Float3.9%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

EFFECT EFFECT Feb 17, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track XRTX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking XRTX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for XRTX
📊 XRTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 XRTX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.